Covalon Technologies Ltd. (TSXV:COV)
1.920
-0.020 (-1.03%)
Dec 1, 2025, 3:00 PM EST
Covalon Technologies Revenue
Covalon Technologies had revenue of 8.37M CAD in the quarter ending June 30, 2025, a decrease of -9.24%. This brings the company's revenue in the last twelve months to 32.99M, up 13.00% year-over-year. In the fiscal year ending September 30, 2024, Covalon Technologies had annual revenue of 31.17M with 17.20% growth.
Revenue (ttm)
32.99M
Revenue Growth
+13.00%
P/S Ratio
1.61
Revenue / Employee
891.67K
Employees
37
Market Cap
53.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 31.17M | 4.57M | 17.20% |
| Sep 30, 2023 | 26.60M | 8.45M | 46.56% |
| Sep 30, 2022 | 18.15M | -1.41M | -7.23% |
| Sep 30, 2021 | 19.56M | 6.05M | 44.81% |
| Sep 30, 2020 | 13.51M | -20.50M | -60.27% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |
Covalon Technologies News
- 11 days ago - Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength - Business Wire
- 5 weeks ago - Covalon Declares First Ever Special Cash Dividend - Business Wire
- 6 weeks ago - Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025 - Business Wire
- 7 weeks ago - Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference - Business Wire
- 2 months ago - Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON - Business Wire
- 2 months ago - Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair - Business Wire
- 2 months ago - Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting - Business Wire
- 2 months ago - Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs) - Business Wire